Screening for primary aldosteronism in a cohort of Brazilian patients with resistant hypertension

Journal of Clinical Hypertension

Volumn 10, Issue 8, 2008, Pages 619-623

  Nogueira, Armando R ^a   Bloch, Katia V ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; ANTIHYPERTENSIVE AGENT; RENIN;

ABDOMINAL RADIOGRAPHY; ADRENAL CORTEX ADENOMA; ADRENAL GLAND; ADULT; ALDOSTERONE BLOOD LEVEL; ALDOSTERONE PRODUCING ADENOMA; ALDOSTERONE RELEASE; ARTICLE; BLOOD PRESSURE MEASUREMENT; BRAZIL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DIFFERENTIAL DIAGNOSIS; ESSENTIAL HYPERTENSION; FEMALE; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; IMAGE ANALYSIS; KIDNEY DISEASE; LOADING TEST; LOW RENIN HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; PATIENT COMPLIANCE; PLASMA RENIN ACTIVITY; PRIMARY HYPERALDOSTERONISM; PRIORITY JOURNAL; ADENOMA; ADRENAL TUMOR; AGED; BLOOD; HYPERALDOSTERONISM; HYPERPLASIA; MIDDLE AGED; PATHOLOGY; RADIOGRAPHY;

ADENOMA; ADRENAL GLAND NEOPLASMS; ADRENAL GLANDS; AGED; ALDOSTERONE; BRAZIL; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; HYPERALDOSTERONISM; HYPERPLASIA; HYPERTENSION; MALE; MASS SCREENING; MIDDLE AGED; RENIN; TOMOGRAPHY, X-RAY COMPUTED;

EID: 52649177255     PISSN: 15246175     EISSN: 17517176     Source Type: Journal    
DOI: 10.1111/j.1751-7176.2008.08421.x     Document Type: Article

References (20)

1. Stewart PM. Mineralocorticoid hypertension. Lancet. 1999;353:1341-1347.
2. Hiramatsu K, Yamada T, Jukimura Y, et al. A screening test to identify aldosterone-producing adenoma by measuring plasma renin activity. Arch Intern Med. 1981;141:1589-1594.
3. Calhoun DA, Nishizaka MK, Zaman MA, et al. Hyperaldosteronism among black and white subjects with resistant hypertension. Hypertension. 2002;40:892-896.
4. Epstein M. Aldosterone blockade: An emerging strategy for abrogating progressive renal disease. Am J Med. 2006;119:912-919.
5. Mulatero P, Dluhy RG, Giachetti G, et al. Diagnosis of primary aldosteronism: From screening to subtype differentiation. Trends Endocrinol Metab. 2005;16:114-119.
6. Mulatero P, Milan A, Fallo F, et al. Comparison of confirmatory tests for diagnosis of primary aldosteronism. J Clin Endocrinol Metab. 2006;91:2618-2623.
7. Stowasser M, Gordon RD, Gunasekera TG, et al. High rate of detection of primary aldosteronism, including surgically treatable forms, after "non-selective" screening of hypertensive patients. J Hypertens. 2003;21:2149-2157.
8. Salles G, Leocadio S, Bloch K, et al. Combined QT interval and voltage criteria improve left ventricular hypertrophy detection in resistant hypertension. Hypertension. 2005;46:1207-1212.
9. Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986;24:67-74.
10. Hood S, Cannon J, Foo R, et al. Prevalence of primary hyperaldosteronism assessed by aldosterone/renin ratio and spironolactone testing. Clin Med. 2005;5:55-60.
11. Lim PO, Rodgers P, Cardale K, et al. Potentially high prevalence of primary aldosteronism in a primary-care population. Lancet. 1999;353:40.
12. Schwartz GL, Turner ST. Screening for primary aldosteronism in essential hypertension: Diagnostic accuracy of the ratio of plasma aldosterone concentration to plasma renin activity. Clin Chem. 2005;51:386-394.
13. Nishizaka MK, Pratt-Ubunama M, Zaman MA, et al. Validity of plasma aldosterone-to-renin activity ratio in African American and white subjects with resistant hypertension. Am J Hypertens. 2005;18:805-812.
14. Young WF Jr. The incidentally discovered adrenal mass. N Engl J Med. 2007;356:601-610.
15. Rutherford JC, Taylor WL, Stowasser M, et al. Succcess of surgery in primary aldosteronism judged by residual autonomous aldosterone production. World J Surg. 1998;22:1243-1245.
16. Nwariaku FE, Miller BS, Auchus R, et al. Primary hyperaldosteronism: effect of adrenal vein sampling on surgical outcome. Arch Surg. 2006;141:497-502.
17. Kaplan NM. The current epidemic of primary aldosteronism: Cause and consequences. J Hypertens. 2004;22:863-869.
18. Chapman N, Dobson J, Wilson S; Anglo-Scandinavian Cardiac Outcomes Trials Investigators. Effect of spironolactone on blood pressure in subjects with resistant hypertension. Hypertension. 2007;49:839-845.
19. Lim PO, Struthers AD, MacDonald TM. The neurohormonal natural history of essential hypertension: Towards primary or tertiary aldosteronism? J Hypertens. 2002;20:11-15.
20. Padfield PL. Prevalence and role of raised aldosterone to renin ratio in the diagnosis of primary aldosteronism: A debate on the scientific logic of the use of the ratio in practice. Clin Endocrinol (Oxf). 2003;59:422-426.